Zentalis Pharmaceuticals Inc.
Organization details
- Legal name
- Zentalis Pharmaceuticals Inc.
- Former names
- Zeno Pharma, LLC
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Headquarters city
- SAN Diego
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ZNTL
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001725160
- EIN
- 82-3607803
Board of directors
-
Cam Gallagher · Director · President, Interim CFOSince 2023
-
David Michael Johnson · DirectorSince 2023
-
Diana Hausman · DirectorSince 2023
-
Enoch Kariuki · DirectorSince 2023
-
Jan Skvarka · DirectorSince 2023
-
Julia Marie Eastland · Director · CEO & PresidentSince 2024
-
Kimberly Blackwell · Director · Chief Executive OfficerSince 2023
-
Luke Nathaniel Walker · DirectorSince 2024
-
Scott Dunseth Myers · DirectorSince 2024
-
Shannon Campbell · DirectorSince 2026
Chief executives
Director election results
Annual meeting of June 16, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
71.4%
Board connections
9 of this board's directors also sit on 11 other boards. 11 are in the same sector.
-
Monte Rosa Therapeutics Inc. Same sectorvia Jan Skvarka and Kimberly Blackwell
-
Aura Biosciences Inc. Same sectorvia David Michael Johnson
-
Black Diamond Therapeutics Inc. Same sectorvia Shannon Campbell
-
CalciMedica Inc. Same sectorvia Julia Marie Eastland
-
Cartesian Therapeutics Inc. Same sectorvia Scott Dunseth Myers
-
Century Therapeutics Inc. Same sectorvia Kimberly Blackwell
-
Context Therapeutics Inc. Same sectorvia Luke Nathaniel Walker
-
Immuneering Corporation Same sectorvia Diana Hausman
-
Lantheus Holdings Inc. Same sectorvia Julia Marie Eastland
-
Opus Genetics Inc. Same sectorvia Cam Gallagher
-
Viridian Therapeutics Inc. Same sectorvia Scott Dunseth Myers
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $22,924,468
- 2 purchases by 1 insider
- Sold, last 12 months
- $10,109,656
- 10 sales by 4 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 30, 2026 | Bruns Ingmar Officer (Chief Medical Officer) | Grant or award | +9,727 | $2.18 | $21,205 |
| Aug 14, 2026 | WALTERS WILLIAM THURMAN 10% owner | Open-market purchase | +4,335,000 | $3.50 | $15,172,500 |
| Jun 16, 2026 | David Michael Johnson Director | Grant or award | +57,100 | — | — |
| Jun 16, 2026 | Jan Skvarka Director | Grant or award | +57,100 | — | — |
| Jun 16, 2026 | Luke Nathaniel Walker Director | Grant or award | +57,100 | — | — |
| Jun 16, 2026 | Enoch Kariuki Director | Grant or award | +57,100 | — | — |
| Jun 16, 2026 | Scott Dunseth Myers Director | Grant or award | +57,100 | — | — |
| May 26, 2026 | Shannon Campbell Director | Grant or award | +114,200 | — | — |
| Feb 10, 2026 | Vultaggio Vincent Officer (PAO and PFO) | Open-market sale | −6,894 | $2.42 | $16,683 |
| Feb 9, 2026 | Bruns Ingmar Officer (Chief Medical Officer) | Open-market sale | −335 | $2.39 | $801 |
| Feb 9, 2026 | Vultaggio Vincent Officer (PAO and PFO) | Open-market sale | −3,379 | $2.39 | $8,076 |
| Feb 9, 2026 | Julia Marie Eastland Director, Officer (CEO & President) | Open-market sale | −889 | $2.39 | $2,125 |
| Feb 6, 2026 | Bruns Ingmar Officer (Chief Medical Officer) | Open-market sale | −2,962 | $2.43 | $7,198 |
| Feb 6, 2026 | Vultaggio Vincent Officer (PAO and PFO) | Open-market sale | −29,951 | $2.43 | $72,781 |
| Feb 6, 2026 | Julia Marie Eastland Director, Officer (CEO & President) | Open-market sale | −7,866 | $2.43 | $19,114 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Zentalis Pharmaceuticals Inc.
Who is the CEO of Zentalis Pharmaceuticals Inc.?
Julia Marie Eastland has been Zentalis Pharmaceuticals Inc.'s CEO & President since November 2024.
How many directors are on Zentalis Pharmaceuticals Inc.'s board?
Zentalis Pharmaceuticals Inc.'s board has 10 directors: Cam Gallagher, David Michael Johnson, Diana Hausman, Enoch Kariuki, Jan Skvarka, Julia Marie Eastland, Kimberly Blackwell, Luke Nathaniel Walker, Scott Dunseth Myers and Shannon Campbell.
Are Zentalis Pharmaceuticals Inc. insiders buying or selling shares?
Over the last 12 months, Zentalis Pharmaceuticals Inc. insiders bought $22.9 million of shares in 2 purchases and sold $10.1 million of shares in 10 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="zentalis-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.